Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic surgery: a randomized controlled trial
Key facts
- Where
- Amiens Cedex 1, FranciaországSee the site
- Phase
- 4. fázis
Where in Franciaország
- Centre Hospitalier Universitaire Amiens PicardieAmiens Cedex 1, FranciaországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier Universitaire Amiens Picardie
- Trial code
- EU 2025-523207-29-00
- Record updated
- 2026. szeptember 22.
- Original description
Evaluate the effectiveness of combining intravenous lidocaine and ropivacaine infiltration of laparoscopic trocar sites on postoperative recovery as assessed using the QOR-15 twenty-four hours after colorectal surgery.Read full original descriptionShow less
Evaluate the effectiveness of combining intravenous lidocaine and ropivacaine infiltration of laparoscopic trocar sites on postoperative recovery as assessed using the QOR-15 twenty-four hours after colorectal surgery.
Inclusion: Patients undergoing scheduled laparoscopic colorectal cancer surgery; Patients aged 18 years or older; Highly effective method of contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intravaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, intrauterine hormone-releasing system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence; Informed consent and signed agreement; Enrollment in a Social Security plan.
Exclusion: Colorectal surgery by laparotomy; Allergy or contraindication to lidocaine or ropivacaine,; Allergy or contraindication to paracetamol, nefopam, ketamine, propofol, dexamethasone, sufentanil , Celebrex or Parecoxib, , morphine derivatives, and Colorectal surgery by laparotomy; Colorectal surgery not indicated for cancer treatment; Patients suffering from psychiatric disorders; Patients under guardianship, conservatorship, or legal protection; Chronic preoperative pain (defined as pain persisting for more than 3 months),; Preoperative use of opioids or opioid derivatives,; Patients for whom pain self-assessment using a self-assessment scale cannot be performed (non-communicative, non-English-speaking, etc.); Pregnant or breastfeeding women.